Literature DB >> 19225531

Preparation for surgery of phaeochromocytoma by blockade of alpha-adrenergic receptors with urapidil: what dose?

P Gosse1, P Tauzin-Fin, M-B Sesay, A Sautereau, P Ballanger.   

Abstract

The preparation for phaeochromocytoma surgery is a matter of debate. Pre-operative blockade of alpha-1 receptors is increasingly employed in an attempt to reduce the risk of hypertensive episodes, especially during manipulation of the tumour. In this study, we compared the interest of an almost complete blockade of these receptors by high doses of urapidil in comparison with that of moderate doses of this drug. The study was conducted in two consecutive series of 18 patients, the first treated by a moderate dose, and the second by the highest dose tolerated by the patient. The two groups were comparable in other respects. All patients were operated under laparoscopy by the same surgeon and managed by the same anaesthetist using the same protocol. The number of hypertensive peaks was significantly reduced using the high dose of urapidil, with no more hypotensive episodes after tumour removal in this group. The area under the curve of norepinephrine levels as a function of time was significantly larger with the high doses of urapidil, arguing in favour of a more complete blockade of alpha-1 receptors. Our findings indicate the value of aggressive blockade of alpha-1 receptors in preparation for surgery of phaeochromocytoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19225531     DOI: 10.1038/jhh.2008.172

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  4 in total

Review 1.  Perioperative hemodynamic instability in patients undergoing laparoscopic adrenalectomy for pheochromocytoma.

Authors:  Magdalena Pisarska; Michał Pędziwiatr; Andrzej Budzyński
Journal:  Gland Surg       Date:  2016-10

2.  Urapidil in the preoperative treatment of pheochromocytomas: a safe and cost-effective method.

Authors:  Nils Habbe; Florian Ruger; Jorg Bojunga; Wolf Otto Bechstein; Katharina Holzer
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

3.  PATIENTS' SAFETY AND FEASIBILITY OF INTRAVENOUS URAPIDIL IN THE PRETREATMENT OF PHEOCHROMOCYTOMA PATIENTS IN A NORMAL WARD SETTING - AN ANALYSIS OF 20 CONSECUTIVE CASES.

Authors:  A Reinisch; K Holzer; J Bojunga; W O Bechstein; N Habbe
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Oct-Dec       Impact factor: 0.877

4.  Peri-operative management of pheochromocytoma with intravenous urapidil to prevent hemodynamic instability: A 17-year experience.

Authors:  Patrick Tauzin-Fin; Kévin Barrucand; Musa Sesay; Stéphanie Roullet; Philippe Gosse; Jean-Christophe Bernhard; Gregoire Robert; François Sztark
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2020-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.